# Safety and Efficacy of CRD007 in Adult Asthma Subjects

> **NCT02615080** · PHASE2 · COMPLETED · sponsor: **RSPR Pharma AB** · enrollment: 168 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CRD007
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02615080
- **Lead sponsor:** RSPR Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-30
- **Primary completion:** 2017-02-21
- **Final completion:** 2017-02-24
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615080, "Safety and Efficacy of CRD007 in Adult Asthma Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02615080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*